Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trialFlorence Ader, Raphaël Clère-Jehl, Maude Bouscambert‐Duchamp et al.|The Lancet Infectious Diseases|2021Cited by 344
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trialsAlain Amstutz, Matthias Briel, Drifa Belhadi et al.|The Lancet Respiratory Medicine|2023Cited by 124